Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$46,906,481
-$202,021,926 QoQ
Shares Held
184,693
-81.9% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#460
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 30%
Shared 0%
None 70%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LSV ASSET MANAGEMENT holds $2,451,058,699 across 9 Drug Manufacturers - General names. JNJ ranks #8 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
5,299,408 | $680,973,928 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
9,852,232 | $567,685,607 | |
| 3 | PFE |
Pfizer Inc
|
18,940,504 | $456,087,336 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
2,635,721 | $332,996,991 | |
| 5 | AMGN |
Amgen Inc
|
603,549 | $218,557,163 | |
| 6 | BIIB |
Biogen Inc.
|
444,049 | $95,941,226 | |
| 7 | OGN |
Organon & Co.
|
3,737,036 | $50,599,467 | |
| 8 | JNJ |
Johnson & Johnson
This page
|
184,693 | $46,906,481 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,906,481 | 184,693 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $248,928,407 | 1,018,362 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $396,621,330 | 1,916,508 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $569,305,780 | 3,070,358 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $481,362,908 | 3,151,312 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $541,425,144 | 3,264,744 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $500,478,046 | 3,460,642 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $561,926,844 | 3,467,400 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $435,201,631 | 2,977,570 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $337,920,732 | 2,136,170 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $340,973,763 | 2,175,410 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $350,713,177 | 2,251,770 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $196,288,512 | 1,185,890 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $174,443,200 | 1,125,440 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $204,002,486 | 1,154,840 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $240,616,211 | 1,472,920 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $278,794,365 | 1,570,584 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $308,777,726 | 1,742,243 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $293,683,225 | 1,716,743 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $289,334,194 | 1,791,543 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $242,183,944 | 1,470,098 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $235,470,819 | 1,432,740 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $298,021,063 | 1,893,640 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $572,676,001 | 3,846,561 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $566,100,299 | 4,025,459 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $552,282,319 | 4,211,716 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||